vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) has entered into a license deal with Danish
SolStock/E+ via Getty Images AbbVie (NYSE:ABBV) announced Friday that an expert panel of the EU
mohd izzuan/iStock via Getty Images Responding to a lawsuit by Novartis (NVS), the U.S. Department
JHVEPhoto Teva Pharmaceutical (NYSE:TEVA) and Alvotech (NASDAQ:ALVO) have launched their biosimilar targeting Johnson & Johnson’s
franckreporter/iStock via Getty Images Deutsche Bank upgraded Gilead Sciences (NASDAQ:GILD) on Tuesday, citing the antiviral
Igor Kutyaev/iStock via Getty Images BMO Capital Markets expects to see a relative improvement in
Igor Kutyaev/iStock via Getty Images BMO Capital Markets expects to see a relative improvement in
AbbVie (NYSE:ABBV) has elected Chief Executive Officer Robert Michael to assume the additional position of
AbbVie (NYSE:ABBV) has elected Chief Executive Officer Robert Michael to assume the additional position of
AbbVie (NYSE:ABBV) declared $1.64/share quarterly dividend, in line with previous. Forward yield 3.4% Payable May 15;